McCarthy Tétrault advised Feldan on the deal. Feldan Bio Inc. (“Feldan”) completed a C$16.5 million Series B investment round that will see new investors Investissement Québec,...
Feldan Bio’s C$16.5 Million Series B investment
IMV’s $9 Million Offering
McCarthy Tétrault LLP advised IMV on the offering. On December 20, 2022, IMV Inc., closed its previously announced registered direct offering for total gross proceed of...
SPS Commerce, Inc.’s Share Purchase Agreement with mdf commerce and Acquisition of InterTrade Systems Inc.
McCarthy Tétrault advised mdf commerce inc. on the matter. mdf commerce inc. (TSX:MDF), a SaaS leader in digital commerce technologies, entered into a share purchase agreement with SPS Commerce,...
Medicenna Therapeutics Corp.’s $20 Million Capital Raise
McCarthy Tétrault advised Medicenna Therapeutics Corp. on the matter. On August 11, 2022, Medicenna Therapeutics Corp. closed its previously announced marketed underwritten public offering of units in Canada and in the United States for an...
SATO Technologies Corp.’s CHF3 Million Agreement with Sygnum Bank AG
McCarthy Tétrault advised Canada Computational Unlimited Inc. on the matter. On July 15, 2022, SATO Technologies Corp. (“SATO”), announced the signing of a loan agreement through...
Capricorn Business Acquisitions Inc.’s C$32 Million Acquisition of Canada Computational Unlimited Inc.
McCarthy Tétrault LLP advised Canada Computational Unlimited Inc. on the transaction. On September 7, 2021, Canada Computational Unlimited Inc., was acquired by Capricorn Business Acquisitions Inc. effected through a reverse...
IMV Inc.’s $25 Million Public Offering
McCarthy Tétrault advised IMV in connection with the offering. On July 20, 2021, IMV Inc. closed an underwritten public offering of 14,285,714 units, for total gross...